Developmental Regulation of MicroRNA Expression in Schwann Cells

REFERENCES

• Addo-Yobo SO, et al. 2006. Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma. J. Neuropathol Exp. Neurol. 65: 769–775.
   PubMedGoogle Scholar
• Atanasoski S, et al. 2006. Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation. Glia 53: 147–157.
   PubMedGoogle Scholar
• Awatramani R, Shumas S, Kamholz J, Scherer SS. 2002. TGFbeta1 modulates the phenotype of Schwann cells at the transcriptional level. Mol. Cell. Neurosci. 19: 307–319.
   PubMedGoogle Scholar
• Bourikas D, Mir A, Walmsley AR. 2010. LINGO-1-mediated inhibition of oligodendrocyte differentiation does not require the leucine-rich repeats and is reversed by p75(NTR) antagonists. Mol. Cell. Neurosci. 45: 363–369.
   PubMed Web of Science ®Google Scholar
• Bremer J, et al. 2010. Ablation of Dicer from murine Schwann cells increases their proliferation while blocking myelination. PLoS One 5: e12450.
   PubMed Web of Science ®Google Scholar
• Bremer M, et al. 2011. Sox10 is required for Schwann-cell homeostasis and myelin maintenance in the adult peripheral nerve. Glia 59: 1022–1032.
   PubMedGoogle Scholar
• Britsch S, et al. 2001. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 15: 66–78.
   PubMed Web of Science ®Google Scholar
• Buchstaller J, et al. 2004. Efficient isolation and gene expression profiling of small numbers of neural crest stem cells and developing Schwann cells. J. Neurosci. 24: 2357–2365.
   PubMedGoogle Scholar
• Budde H, et al. 2010. Control of oligodendroglial cell number by the miR-17-2 cluster. Development 137: 2127–2132.
   PubMedGoogle Scholar
• D'Antonio M, et al. 2006. Gene profiling and bioinformatic analysis of Schwann cell embryonic development and myelination. Glia 53: 501–515.
   PubMed Web of Science ®Google Scholar
• Diosdado B, et al. 2009. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br. J. Cancer 101: 707–714.
   PubMed Web of Science ®Google Scholar
• Dugas JC, et al. 2010. Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65: 597–611.
   PubMed Web of Science ®Google Scholar
• Dugas JC, Notterpek L. 2011. MicroRNAs in oligodendrocyte and Schwann cell differentiation. Dev. Neurosci. 33: 14–20.
   PubMedGoogle Scholar
• Ferletta M, Uhrbom L, Olofsson T, Pontén F, Westermark B. 2007. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B-induced gliomagenesis. Mol. Cancer Res. 5: 891–897.
   PubMed Web of Science ®Google Scholar
• Finzsch M, et al. 2010. Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J. Cell Biol. 189: 701–712.
   PubMedGoogle Scholar
• Finzsch M, Stolt CC, Lommes P, Wegner M. 2008. Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression. Development 135: 637–646.
   PubMed Web of Science ®Google Scholar
• Fujita PA, et al. 2011. The UCSC Genome Browser database: update 2011. Nucleic Acids Res. 39: D876–D882.
   PubMed Web of Science ®Google Scholar
• Garzon R, Calin GA, Croce CM. 2009. MicroRNAs in cancer. Annu. Rev. Med. 60: 167–179.
   PubMed Web of Science ®Google Scholar
• Ghislain J, Charnay P. 2006. Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities. EMBO Rep. 7: 52–58.
   PubMedGoogle Scholar
• Gibbs RA, et al. 2004. Genome sequence of the brown Norway rat yields insights into mammalian evolution. Nature 428: 493–521.
   PubMed Web of Science ®Google Scholar
• Hai M, Muja N, DeVries GH, Quarles RH, Patel PI. 2002. Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J. Neurosci. Res. 69: 497–508.
   PubMedGoogle Scholar
• He L, et al. 2005. A microRNA polycistron as a potential human oncogene. Nature 435: 828–833.
   PubMed Web of Science ®Google Scholar
• He X, Yu Y, Awatramani R, Lu QR. 2 May 2011, posting date. Unwrapping myelination by microRNAs. Neuroscientist [Epub ahead of print.] https://doi.org/10.1177/1073858410392382.
   Google Scholar
• Honoré SM, Aybar MJ, Mayor R. 2003. Sox10 is required for the early development of the prospective neural crest in Xenopus embryos. Dev. Biol. 260: 79–96.
   PubMed Web of Science ®Google Scholar
• Ivanovska I, et al. 2008. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 28: 2167–2174.
   PubMed Web of Science ®Google Scholar
• Jang SW, et al. 2010. Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes. J. Neurochem. 115: 1409–1420.
   PubMedGoogle Scholar
• Jang SW, Svaren J. 2009. Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements. J. Biol. Chem. 284: 20111–20120.
   PubMedGoogle Scholar
• Jessen KR, Mirsky R. 2005. The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci. 6: 671–682.
   PubMed Web of Science ®Google Scholar
• Johansson FK, et al. 2004. Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging. Proc. Natl. Acad. Sci. U. S. A. 101: 11334–11337.
   PubMed Web of Science ®Google Scholar
• Jones EA, et al. 2007. Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol. 3: 377–387.
   PubMedGoogle Scholar
• Jones EA, et al. 2011. Regulation of the PMP22 gene through an intronic enhancer. J. Neurosci. 31: 4242–4250.
   PubMed Web of Science ®Google Scholar
• Kim J, Lo L, Dormand E, Anderson DJ. 2003. SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron 38: 17–31.
   PubMed Web of Science ®Google Scholar
• Leblanc SE, et al. 2005. Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination. J. Neurochem. 93: 737–748.
   PubMedGoogle Scholar
• LeBlanc SE, Ward RM, Svaren J. 2007. Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10. Mol. Cell. Biol. 27: 3521–3529.
   PubMed Web of Science ®Google Scholar
• Liang Y, Ridzon D, Wong L, Chen C. 2007. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8: 166.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(− Delta Delta C(T)) method. Methods 25: 402–408.
   PubMed Web of Science ®Google Scholar
• Mager GM, et al. 2008. Active gene repression by the EGR2/NAB complex during peripheral nerve myelination. J. Biol. Chem. 283: 18187–18197.
   PubMed Web of Science ®Google Scholar
• Maunakea AK, et al. 2010. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466: 253–257.
   PubMed Web of Science ®Google Scholar
• Murchison EP, et al. 2010. The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer. Science 327: 84–87.
   PubMed Web of Science ®Google Scholar
• Nagarajan R, et al. 2001. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30: 355–368.
   PubMed Web of Science ®Google Scholar
• Nave KA, Salzer JL. 2006. Axonal regulation of myelination by neuregulin 1. Curr. Opin. Neurobiol. 16: 492–500.
   PubMed Web of Science ®Google Scholar
• O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839–843.
   PubMed Web of Science ®Google Scholar
• Olive V, Jiang I, He L. 2010. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell Biol. 42: 1348–1354.
   PubMed Web of Science ®Google Scholar
• Parkinson DB, et al. 2004. Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death. J. Cell Biol. 164: 385–394.
   PubMedGoogle Scholar
• Peirano RI, Goerich DE, Riethmacher D, Wegner M. 2000. Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol. Cell. Biol. 20: 3198–3209.
   PubMedGoogle Scholar
• Peirano RI, Wegner M. 2000. The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res. 28: 3047–3055.
   PubMedGoogle Scholar
• Pereira JA, et al. 2010. Dicer in Schwann cells is required for myelination and axonal integrity. J. Neurosci. 30: 6763–6775.
   PubMedGoogle Scholar
• Petrocca F, et al. 2008. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272–286.
   PubMed Web of Science ®Google Scholar
• Plasterk RH. 2006. Micro RNAs in animal development. Cell 124: 877–881.
   PubMed Web of Science ®Google Scholar
• Pospisil V, et al. 2011. Epigenetic silencing of the oncogenic miR-17-92 cluster during PU. 1-directed macrophage differentiation. EMBO J. 30: 4450–4464.
   PubMedGoogle Scholar
• Reiprich S, Kriesch J, Schreiner S, Wegner M. 2010. Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells. J. Neurochem. 112: 744–754.
   PubMed Web of Science ®Google Scholar
• Rimsza LM, et al. 2008. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. Blood 112: 3425–3433.
   PubMed Web of Science ®Google Scholar
• Roberts RA, et al. 2007. Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma. Lab Invest. 87: 979–997.
   PubMed Web of Science ®Google Scholar
• Roh J, et al. 2006. Down-regulation of Sox10 with specific small interfering RNA promotes transdifferentiation of Schwannoma cells into myofibroblasts. Differentiation 74: 542–551.
   PubMedGoogle Scholar
• Schulte JH, et al. 2008. MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int. J. Cancer 122: 699–704.
   PubMed Web of Science ®Google Scholar
• Scott CE, et al. 2010. SOX9 induces and maintains neural stem cells. Nat. Neurosci. 13: 1181–1189.
   PubMed Web of Science ®Google Scholar
• Sonnenberg-Riethmacher E, et al. 2001. Development and degeneration of dorsal root ganglia in the absence of the HMG-domain transcription factor Sox10. Mech. Dev. 109: 253–265.
   PubMedGoogle Scholar
• Stolt CC, et al. 2002. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev. 16: 165–170.
   PubMed Web of Science ®Google Scholar
• Stolt CC, Wegner M. 2010. SoxE function in vertebrate nervous system development. Int. J. Biochem. Cell Biol. 42: 437–440.
   PubMedGoogle Scholar
• Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. 2008. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124–1128.
   PubMed Web of Science ®Google Scholar
• Topilko P, et al. 1994. Krox-20 controls myelination in the peripheral nervous system. Nature 371: 796–799.
   PubMed Web of Science ®Google Scholar
• Uren AG, et al. 2008. Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 133: 727–741.
   PubMedGoogle Scholar
• Valouev A, et al. 2008. Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data. Nat. Methods 5: 829–834.
   PubMed Web of Science ®Google Scholar
• Ventura A, et al. 2008. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132: 875–886.
   PubMed Web of Science ®Google Scholar
• Verheijen MH, Chrast R, Burrola P, Lemke G. 2003. Local regulation of fat metabolism in peripheral nerves. Genes Dev. 17: 2450–2464.
   PubMedGoogle Scholar
• Verrier JD, et al. 2009. Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a. Glia 57: 1265–1279.
   PubMedGoogle Scholar
• Verrier JD, Semple-Rowland S, Madorsky I, Papin JE, Notterpek L. 2010. Reduction of Dicer impairs Schwann cell differentiation and myelination. J. Neurosci. Res. 88: 2558–2568.
   PubMedGoogle Scholar
• Wegner M, Stolt CC. 2005. From stem cells to neurons and glia: a Soxist's view of neural development. Trends Neurosci. 28: 583–588.
   PubMed Web of Science ®Google Scholar
• Wong P, et al. 2010. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. Cancer Res. 70: 3833–3842.
   PubMed Web of Science ®Google Scholar
• Woodhoo A, et al. 2009. Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity. Nat. Neurosci. 12: 839–847.
   PubMed Web of Science ®Google Scholar
• Yun B, et al. 2010. MicroRNA-deficient Schwann cells display congenital hypomyelination. J. Neurosci. 30: 7722–7728.
   PubMed Web of Science ®Google Scholar
• Zhao X, et al. 2010. MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 65: 612–626.
   PubMed Web of Science ®Google Scholar
• Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G. 1996. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol. Cell. Neurosci. 8(23): 129–145.
   Google Scholar
• Zorick TS, Syroid DE, Brown A, Gridley T, Lemke G. 1999. Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells. Development 126: 1397–1406.
   PubMedGoogle Scholar